Potassium-Sparing Diuretics Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck Sharp & Dohme Corp.
- Accord Healthcare
- Amneal Pharmaceuticals LLC
- Centaur Pharmaceuticals Pvt. Ltd.
- Validus Pharmaceuticals LLC
- Teva Pharmaceutical Industries Ltd.
- CMP Pharma
- Boehringer Ingelheim GmbH
- Bayer AG
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of potassium-sparing diuretics is estimated at USD 129.39 million.
The global potassium-sparing diuretics market size crossed USD 122.87 million in 2025 and is likely to register a CAGR of over 5.9%, exceeding USD 217.97 million revenue by 2035.
By 2035, North America is anticipated to capture a 39% share of the potassium-sparing diuretics market, stemming from the increasing prevalence of cardiovascular diseases and the rising demand for safe and effective medicines.
Key players in the market include Pfizer Inc., Merck Sharp & Dohme Corp., Accord Healthcare, Amneal Pharmaceuticals LLC, Centaur Pharmaceuticals Pvt. Ltd., Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., CMP Pharma, Boehringer Ingelheim GmbH, Bayer AG.
